Fonar Corp FONR

An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.

In plain words · FONAR Corporation, together with its subsidiaries, engages in the designing, manufacturing, selling, and servicing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormali…

The label

Accumulation

read at $19.09

Fonar Corp holds its Accumulation at $19.09.

PHPhase · the trend structure carries the Accumulation label
INInsiders · no filings inside 60 days, left as found
POPositioning · no disclosures inside 60 days, left as found
OPOptions · no verdict drawn today, left as found
SCScreen · passes the values gate

edge confirmed
edge broken
edge forming

Each arm is one independent read. Conviction is not a single call, it is how many edges converge.

The investor read · the season, not the day

As held on the ledger · 2025-06-30
Phase	Accumulation
Quantitative state	The statistical read favours the buyers, held for 41 days
Price	$19.09
Valuation	19.09 trailing · N/A forward price to earnings
Values screen	PASS · score 70.0
Beta	0.96

The business, in plain words · what the numbers mean

The fundamentals · plain-English read
Trailing P/E	19.1x reasonably valued
Revenue growth	-2.6% revenue is shrinking
Profit margin	6.4% thin but positive margins
Return on equity	5.5% a modest return on shareholder capital
Debt to equity	0.24 minimal debt — a conservative balance sheet
Current ratio	9.18 comfortably covers its short-term bills
Beta	0.96 steadier than the market
Market cap	$120M
Employees	535

The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.

Plain-English interpretation of our own screen data. Analysis, not advice.

Related securities · others in FONR's space worth a look

XGN Exagen Inc BNR Burning Rock Biotech Ltd ADR IMDX Insight Molecular Diagnostics Inc BDSX Biodesix Inc PRE Prenetics Global Limited PRPO Precipio Inc

Screened names in the same industry · explore each on its own page.

The trader read · the latest dated commentary

The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 31%. Our forward projection puts the odds of a 10% gain over the next month near 20%. Entered 2026-07-30 · Accumulation

The dated journal · newest first, never edited

2026-07-30 Accumulation $19.09 +0.0% Entry 4

The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 31%. Our forward projection puts the odds of a 10% gain over the next month near 20%.

2026-07-18 Accumulation $19.09 +0.0% Entry 3

The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 12% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 31%. Our forward projection puts the odds of a 10% gain over the next month near 20%.

2026-07-03 Accumulation $19.09 +0.0% Entry 2

The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.

2026-07-02 Accumulation $19.09 Entry 1

The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

What holding actually paid · price plus dividends

If $1,000 had been placed · historical, not a promise
Period	Price then	Price return	Divs per share	$1,000 became	Total return
1 month	$18.92	+0.9%	·	$1,009	+0.9%
2 months	$18.59	+2.7%	·	$1,027	+2.7%
3 months	$18.53	+3.0%	·	$1,030	+3.0%
6 months	$14.65	+30.4%	·	$1,304	+30.4%
1 year	$14.52	+31.5%	·	$1,315	+31.5%
2 years	$15.07	+26.7%	·	$1,267	+26.7%
3 years	$16.83	+13.4%	·	$1,134	+13.4%
5 years	$18.16	+5.1%	·	$1,051	+5.1%

Historical returns from market close data. Past performance does not guarantee future results.

This entry now belongs to the ledger. Whatever FONR does next, these words stay.

Fonar Corp · FONR · Accumulation · $19.09
Recorded 2025-06-30 · before the outcome · scored mechanically

All of today's entries See the running score

Fonar Corp FONR

This entry now belongs to the ledger. Whatever FONR does next, these words stay.

Before you go